|
Part I Basics of HIV/AIDS |
|
|
|
1 Molecular Biology of HIV/AIDS and Its Clinical Management |
|
|
3 | (4) |
|
1.1 Application of Modern Molecular Biology in HIV Research |
|
|
3 | (2) |
|
1.1.1 Recombination DNA Techniques |
|
|
3 | (1) |
|
1.1.2 Application of Nucleic Acid Hybridization in HIV Research |
|
|
4 | (1) |
|
1.1.3 Recent Development of Molecular Biology Techniques in HIV Research |
|
|
5 | (1) |
|
1.2 Mechanism of Genetic Diagnosis for HIV |
|
|
5 | (2) |
|
1.2.1 HIV Sequence Detection |
|
|
5 | (1) |
|
1.2.2 HIV Sequence Detection for Immune Antibody Negative Individuals |
|
|
6 | (1) |
|
1.2.3 HIV Sequence Detection for Newborns |
|
|
6 | (1) |
|
1.2.4 Detection of HIV Infected Blood Products and Vaccines |
|
|
6 | (1) |
|
|
6 | (1) |
|
2 An Overview of Clinical Immunology of HIV/AIDS |
|
|
7 | (8) |
|
2.1 Defense Mechanism of Organisms |
|
|
7 | (2) |
|
2.1.1 Non-specific Immunity |
|
|
7 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
2.1.4 Chemotactic Factors (CF) |
|
|
8 | (1) |
|
2.2 Mechanism of Immune Response |
|
|
9 | (1) |
|
2.2.1 Antiviral Immune Response |
|
|
9 | (1) |
|
2.2.2 Antibacterial Immune Response |
|
|
9 | (1) |
|
2.2.3 Antiparasitic Immune Response |
|
|
10 | (1) |
|
2.2.4 Anti-tumor Immune Response |
|
|
10 | (1) |
|
|
10 | (1) |
|
2.3.1 Inflammatory Reaction Process (Pathological Response) |
|
|
10 | (1) |
|
2.3.2 Pathophysiological Changes in Stress |
|
|
11 | (1) |
|
2.3.3 Tissues Damage Related to Immune Response |
|
|
11 | (1) |
|
2.4 Immunity Reconstruction |
|
|
11 | (1) |
|
2.5 Pharmacological Basis of Highly Active Antiretroviral Therapy (HARRT) |
|
|
12 | (3) |
|
|
13 | (2) |
|
3 An Overview of Clinical Microbiology of HIV/AIDS |
|
|
15 | (10) |
|
3.1 AIDS Related Pathogenic Microorganisms |
|
|
15 | (3) |
|
3.1.1 Structure and Classification of Pathogenic Microorganisms |
|
|
15 | (1) |
|
3.1.2 Characteristics of Pathogenic Microorganisms |
|
|
16 | (1) |
|
3.1.3 Pathogenicity of Pathogenic Microorganisms |
|
|
17 | (1) |
|
3.2 Methods of Clinical Specimen Collection |
|
|
18 | (1) |
|
3.2.1 Specimens for Virus Isolation, Nucleic Acid and Antigen Detection Should Be |
|
|
18 | (1) |
|
3.2.2 Specified Procedures for Specimen Collection |
|
|
19 | (1) |
|
3.3 Detection of Pathogenic Microorganisms in Opportunistic Infections |
|
|
19 | (2) |
|
3.3.1 Pathogenic Tests in Opportunistic Infections |
|
|
19 | (2) |
|
3.4 Quality Control in Microbiology Laboratory |
|
|
21 | (4) |
|
3.4.1 Maintenance of Equipments in Clinical Microbiologic Laboratory |
|
|
21 | (1) |
|
3.4.2 Quality Control of Bacterial Isolation and Identification |
|
|
21 | (1) |
|
3.4.3 Quality Control of Fungi Isolation and Identification |
|
|
21 | (1) |
|
3.4.4 Quality Control of Drug Sensitivity Test |
|
|
21 | (1) |
|
|
22 | (3) |
|
Part II General Review on HIV/AIDS in Clinical Medicine |
|
|
|
4 Epidemiological Investigation of AIDS |
|
|
25 | (6) |
|
|
25 | (1) |
|
4.2 Sources of Infections |
|
|
26 | (1) |
|
4.3 Routes of Transmission and Population Distribution |
|
|
26 | (1) |
|
4.4 Characteristics of HIV Epidemic |
|
|
27 | (1) |
|
4.5 Epidemiology of HIV/AIDS in China |
|
|
27 | (1) |
|
4.6 Seroepidemiology of HIV/AIDS |
|
|
28 | (1) |
|
4.7 Molecular Epidemiology of HIV/AIDS |
|
|
28 | (1) |
|
4.8 Prevention and Control of HIV/AIDS |
|
|
29 | (2) |
|
|
29 | (2) |
|
5 Pathogenetic and Pathological Mechanism |
|
|
31 | (4) |
|
5.1 Pathogenetic Mechanism |
|
|
31 | (1) |
|
5.1.1 Process of Virus Infection |
|
|
31 | (1) |
|
5.1.2 Anti-HIV Immune Responses |
|
|
32 | (1) |
|
|
32 | (1) |
|
5.2.1 A Drop of CD4 T Lymphocyte Count |
|
|
32 | (1) |
|
5.2.2 Dysfunction of CD4 T Lymphocytes |
|
|
32 | (1) |
|
5.2.3 Abnormal Immunity Activation |
|
|
32 | (1) |
|
5.2.4 Immunity Reconstruction |
|
|
32 | (1) |
|
5.3 Pathology of HIV/AIDS |
|
|
33 | (2) |
|
5.3.1 Common Opportunistic Infections and Malignant Tumors |
|
|
33 | (1) |
|
5.3.2 Pathological Changes of the Immune System |
|
|
34 | (1) |
|
6 Clinical Manifestations of HIV/AIDS Infection |
|
|
35 | (6) |
|
|
35 | (1) |
|
6.2 Clinical Characteristics |
|
|
35 | (1) |
|
6.3 Clinical Symptoms and Signs |
|
|
35 | (1) |
|
|
35 | (1) |
|
|
36 | (1) |
|
|
36 | (1) |
|
6.4 Clinical Classification |
|
|
36 | (1) |
|
|
36 | (1) |
|
6.4.2 Central Nervous Type |
|
|
36 | (1) |
|
6.4.3 Gastrointestinal Type |
|
|
36 | (1) |
|
6.4.4 Fever of Unknown Causes |
|
|
36 | (1) |
|
|
36 | (1) |
|
6.5 Characteristics of Children with HIV/AIDS |
|
|
37 | (1) |
|
6.6 Characteristics of Women with HIV/AIDS |
|
|
37 | (1) |
|
6.7 Diagnostic Criteria and Treatment Guideline for HIV/AIDS in China |
|
|
37 | (4) |
|
7 Laboratory Test and Special Examinations |
|
|
41 | (6) |
|
|
41 | (1) |
|
|
42 | (1) |
|
7.3 Pathological Examinations and Immunohistochemistry |
|
|
42 | (2) |
|
7.3.1 Pathological Examinations |
|
|
42 | (1) |
|
7.3.2 Immunohistochemistry |
|
|
43 | (1) |
|
7.4 Molecular Biological Test |
|
|
44 | (1) |
|
7.4.1 Polymerase Chain Reaction (PCR) |
|
|
44 | (1) |
|
7.4.2 Real-Time Fluorescence Quantitative PCR |
|
|
44 | (1) |
|
7.4.3 Branch DNA Assay (bDNA) |
|
|
44 | (1) |
|
7.4.4 Nucleic Acid Sequence Based Amplification (NASBA) |
|
|
45 | (1) |
|
7.4.5 Transcription Mediated Amplification (TMA) |
|
|
45 | (1) |
|
7.4.6 Ligase Chain Reaction (LCR) |
|
|
45 | (1) |
|
|
45 | (1) |
|
7.6 Gastrointestinal Endoscopy |
|
|
46 | (1) |
|
7.7 CT-Guided Puncture for Biopsy |
|
|
46 | (1) |
|
|
47 | (14) |
|
|
47 | (2) |
|
8.1.1 Diagnostic Imaging Provides Valuable Information for Diagnosis of AIDS Related Diseases |
|
|
47 | (1) |
|
8.1.2 Diagnostic Imaging Provides Information for Differential Diagnosis of AIDS Related Diseases |
|
|
48 | (1) |
|
8.1.3 Application of Diagnostic Imaging in the Observation of Therapeutic Effects During Follow-Ups |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
8.2.2 Gastrointestinal Examinations |
|
|
49 | (1) |
|
8.3 Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI) |
|
|
49 | (2) |
|
8.3.1 Chest Imaging Demonstrations |
|
|
50 | (1) |
|
8.3.2 Imaging Demonstrations of the Digestive System |
|
|
50 | (1) |
|
8.3.3 Imaging Demonstration of the Nervous System |
|
|
51 | (1) |
|
8.4 Positron Emission Tomography-Computed Tomography (PET-CT) |
|
|
51 | (1) |
|
|
52 | (1) |
|
8.4.2 Neurological and Psychiatric Diseases |
|
|
52 | (1) |
|
8.4.3 Cardiovascular Diseases |
|
|
52 | (1) |
|
|
52 | (2) |
|
8.5.1 Ultrasonographic Organs Demonstrations in Patients with AIDS |
|
|
52 | (2) |
|
8.5.2 The Value of Ultrasonography in Diagnostic Imaging of AIDS |
|
|
54 | (1) |
|
8.6 Implications of HIV/AIDS Infection for Health Care Staffs |
|
|
54 | (2) |
|
8.6.1 Occupational Exposure to AIDS in Medical Care |
|
|
54 | (1) |
|
8.6.2 Occupational Protection Against HIV/AIDS in Medical Care |
|
|
55 | (1) |
|
8.7 Relationship Between AIDS and Clinical Medicine |
|
|
56 | (5) |
|
8.7.1 AIDS and Internal Medicine |
|
|
56 | (2) |
|
|
58 | (1) |
|
|
59 | (2) |
|
9 AIDS Imaging and Evidence Based Medicine |
|
|
61 | (4) |
|
9.1 Tasks of Evidence Based AIDS Imaging |
|
|
61 | (1) |
|
9.2 Relationship Between AIDS Imaging and Evidence Based Medicine |
|
|
61 | (1) |
|
9.3 Necessity of Evidence in AIDS Imaging |
|
|
62 | (1) |
|
9.4 Methods and Thinking Way for Evidence in HIV/AIDS Imaging |
|
|
63 | (2) |
|
10 Clinical Medication Against HIV/AIDS |
|
|
65 | (4) |
|
10.1 Development of Therapeutic Medication Against HIV/AIDS |
|
|
65 | (1) |
|
10.2 Therapeutic Efficacy and Adverse Effects of Highly Active Antiretroviral Therapy (HAART) |
|
|
65 | (1) |
|
10.2.1 Virological Indicators |
|
|
65 | (1) |
|
10.2.2 Immunological Indicators |
|
|
66 | (1) |
|
|
66 | (1) |
|
10.3 Clinical Practice of Anti-opportunistic Infections Therapies |
|
|
66 | (1) |
|
10.3.1 Bacterial Infections |
|
|
66 | (1) |
|
|
66 | (1) |
|
10.3.3 Mycobacterial Infections |
|
|
66 | (1) |
|
|
66 | (1) |
|
10.3.5 Pneumocystis Pneumonia (PCP) |
|
|
66 | (1) |
|
|
67 | (1) |
|
10.4 Treatment of HIV/AIDS Related Tumor |
|
|
67 | (2) |
|
11 Introduction to Assessment and Monitoring of Critical AIDS |
|
|
69 | (8) |
|
|
69 | (1) |
|
11.2 HIV/AIDS Related Critical and Severe Opportunistic Infections |
|
|
70 | (1) |
|
11.3 HIV/AIDS Related Advanced Cancer |
|
|
71 | (1) |
|
11.4 HIV/AIDS Related Multiple Organ Failure (MOF) |
|
|
71 | (1) |
|
11.5 HIV/AIDS Related Severe Malnutrition |
|
|
71 | (1) |
|
11.6 HIV/AIDS Related Intensive Care |
|
|
72 | (1) |
|
11.7 HIV/AIDS Related Respiratory Function Monitoring |
|
|
72 | (1) |
|
11.8 HIV/AIDS Related Renal Function Monitoring |
|
|
73 | (1) |
|
11.9 HIV/AIDS Related Cardiovascular Function Monitoring |
|
|
74 | (1) |
|
11.10 HIV/AIDS Related Central Nervous System Function Monitoring |
|
|
74 | (1) |
|
11.11 HIV/AIDS Related Digestive System Function Monitoring |
|
|
75 | (2) |
|
|
76 | (1) |
|
12 HIV Related Effect Factors |
|
|
77 | (6) |
|
12.1 Blood and HIV Infection |
|
|
77 | (1) |
|
12.2 Drug Abuse and HIV Infection |
|
|
78 | (1) |
|
12.3 Sexual Behaviors and HIV Infection |
|
|
78 | (1) |
|
12.4 Mental Health and HIV Infection |
|
|
79 | (1) |
|
12.5 Social Customs & Ethics and HIV Infection |
|
|
79 | (4) |
|
Part III Systematic Review of HIV/AIDS in Clinical Medicine |
|
|
|
13 HIV/AIDS Related Nervous System Diseases |
|
|
83 | (208) |
|
13.1 An Overview of HIV/AIDS Related Nervous System Diseases |
|
|
83 | (7) |
|
13.1.1 HIV-Related Brain Lesions |
|
|
84 | (1) |
|
13.1.2 HIV/AIDS Related Opportunistic Infections |
|
|
84 | (4) |
|
13.1.3 HIV/AIDS Related Nervous System Diseases in Infants |
|
|
88 | (1) |
|
13.1.4 Clinical Manifestations of HIV/AIDS Related Brain Lesions |
|
|
88 | (1) |
|
13.1.5 Clinical Application of HIV/AIDS Related Nerve Imaging |
|
|
88 | (1) |
|
13.1.6 Application and the Future Development of Newly Emerging Imaging Technologies |
|
|
89 | (1) |
|
13.1.7 Prevention and Treatment of the HIV/AIDS Related Nervous System Diseases |
|
|
89 | (1) |
|
13.2 HIV/AIDS Related Encephalopathy |
|
|
90 | (14) |
|
13.2.1 HIV Related Encephalitis and Dementia |
|
|
90 | (13) |
|
13.2.2 Aseptic Meningitis |
|
|
103 | (1) |
|
13.3 HIV/AIDS Related Intracranial Opportunistic Infections |
|
|
104 | (132) |
|
13.3.1 HIV/AIDS Related Intracranial Fungal Infections |
|
|
104 | (36) |
|
13.3.2 HIV/AIDS Related Intracerebral Parasitic Infections |
|
|
140 | (39) |
|
13.3.3 HIV/AIDS Related Intracerebral Viral Infections |
|
|
179 | (35) |
|
13.3.4 HIV/AIDS Related Intracerebral Tuberculosis Infections |
|
|
214 | (15) |
|
13.3.5 HIV/AIDS Related Intracerebral Rhodococcus Equi Infections |
|
|
229 | (3) |
|
13.3.6 HIV/AIDS Related Intracerebral Penicillium Marneffei Infections |
|
|
232 | (4) |
|
13.4 HIV/AIDS Related Cerebral Syphilis |
|
|
236 | (9) |
|
13.4.1 Pathogens and Pathogenesis |
|
|
236 | (1) |
|
13.4.2 Pathophysiological Basis |
|
|
237 | (1) |
|
13.4.3 Clinical Symptoms and Signs |
|
|
237 | (1) |
|
13.4.4 Examinations and Their Selection |
|
|
237 | (1) |
|
13.4.5 Imaging Demonstrations |
|
|
237 | (7) |
|
13.4.6 Criteria for the Diagnosis |
|
|
244 | (1) |
|
13.4.7 Differential Diagnosis |
|
|
244 | (1) |
|
|
244 | (1) |
|
13.5 HIV/AIDS Related Intracranial Tumors |
|
|
245 | (28) |
|
13.5.1 HIV/AIDS Related Intracerebral Non-Hodgkin's Lymphoma |
|
|
245 | (14) |
|
13.5.2 HIV/AIDS Related Intracranial Hodgkin's Lymphoma |
|
|
259 | (1) |
|
13.5.3 HIV/AIDS Related Kaposi's Sarcoma (KS) |
|
|
260 | (1) |
|
13.5.4 HIV/AIDS Related Non-Definitive Tumor |
|
|
260 | (13) |
|
13.6 HIV/AIDS Related Cerebrovascular Diseases |
|
|
273 | (18) |
|
13.6.1 HIV/AIDS Related Cerebral Infarction |
|
|
273 | (4) |
|
13.6.2 HIV/AIDS Related Cerebral Hemorrhage |
|
|
277 | (5) |
|
13.6.3 HIV/AIDS Related Encephalatrophy |
|
|
282 | (4) |
|
|
286 | (5) |
|
14 HIV/AIDS Related Myeleterosis and Peripheral Neuropathy |
|
|
291 | (30) |
|
14.1 Introduction of HIV/AIDS Related Myelopathy and Peripheral Neuropathy |
|
|
291 | (2) |
|
14.1.1 HIV/AIDS Related Spinal Toxoplasma Infection |
|
|
292 | (1) |
|
14.1.2 HIV/AIDS Related Viral Myelitis |
|
|
292 | (1) |
|
14.1.3 HIV/AIDS Related Spinal Bacterial Infection |
|
|
292 | (1) |
|
14.1.4 HIV/AIDS Related Myeloma |
|
|
292 | (1) |
|
14.1.5 Other HIV/AIDS Related Diseases |
|
|
293 | (1) |
|
14.2 HIV/AIDS Related Spinal Toxoplasma Infection |
|
|
293 | (9) |
|
14.2.1 Pathogen and Pathogenesis |
|
|
293 | (1) |
|
14.2.2 Pathophysiological Basis |
|
|
293 | (1) |
|
14.2.3 Clinical Symptoms and Signs |
|
|
293 | (1) |
|
14.2.4 Examinations and the Selection of Examinations |
|
|
293 | (1) |
|
14.2.5 Imaging Demonstrations |
|
|
294 | (8) |
|
14.2.6 Criteria for the Diagnosis |
|
|
302 | (1) |
|
14.2.7 Differential Diagnosis |
|
|
302 | (1) |
|
14.3 HIV/AIDS Related Viral Myelitis |
|
|
302 | (4) |
|
14.3.1 HIV/AIDS Related Herpes Simplex Virus Myelitis |
|
|
302 | (2) |
|
14.3.2 HIV/AIDS Related Cytomegalovirus Myelitis |
|
|
304 | (2) |
|
14.4 HIV/AIDS Related Spinal Bacterial Infection |
|
|
306 | (2) |
|
14.4.1 Staphylococcus Aureus Infection |
|
|
306 | (2) |
|
14.5 HIV/AIDS Related Vacuolar Myelopathy |
|
|
308 | (1) |
|
14.5.1 Pathogen and Pathogenesis |
|
|
308 | (1) |
|
14.5.2 Pathophysiological Basis |
|
|
308 | (1) |
|
14.5.3 Clinical Symptoms and Signs |
|
|
308 | (1) |
|
14.5.4 Examinations and Their Selection |
|
|
308 | (1) |
|
14.5.5 Imaging Demonstrations |
|
|
308 | (1) |
|
14.5.6 Criteria for the Diagnosis |
|
|
308 | (1) |
|
14.5.7 Differential Diagnosis |
|
|
309 | (1) |
|
14.6 HIV/AIDS Related Myelatrophy |
|
|
309 | (5) |
|
14.6.1 Pathogen and Pathogenesis |
|
|
309 | (1) |
|
14.6.2 Pathophysiological Basis |
|
|
309 | (1) |
|
14.6.3 Clinical Symptoms and Signs |
|
|
309 | (1) |
|
14.6.4 Examinations and Their Selection |
|
|
309 | (1) |
|
14.6.5 Imaging Demonstrations |
|
|
309 | (5) |
|
14.6.6 Criteria for the Diagnosis |
|
|
314 | (1) |
|
14.6.7 Differential Diagnosis |
|
|
314 | (1) |
|
14.7 HIV/AIDS Related Peripheral Neuropathy |
|
|
314 | (7) |
|
14.7.1 HIV/AIDS Related Sensory Neuropathy |
|
|
314 | (1) |
|
14.7.2 HIV/AIDS Related Autonomic Neuropathy |
|
|
315 | (1) |
|
14.7.3 Human Cytomegalovirus Myelopathy (HCMV) |
|
|
315 | (1) |
|
14.7.4 Distal Symmetrical Polyneuropathy (DSPN) |
|
|
316 | (1) |
|
14.7.5 Multiple Mononeuropathy |
|
|
316 | (1) |
|
14.7.6 Chronic Infectious Demyelinating Polyneuropathy (CIDP) |
|
|
316 | (4) |
|
|
320 | (1) |
|
15 HIV/AIDS Related Eye Diseases |
|
|
321 | (34) |
|
15.1 Introduction to HIV/AIDS Related Oculopathy |
|
|
321 | (2) |
|
15.1.1 HIV/AIDS Related Retinitis |
|
|
321 | (1) |
|
15.1.2 Cytomegalovirus (CMV) Infection |
|
|
322 | (1) |
|
15.1.3 Herpes Virus Induced Lesions |
|
|
322 | (1) |
|
15.1.4 Toxoplasma Retinitis |
|
|
322 | (1) |
|
|
322 | (1) |
|
|
323 | (1) |
|
15.2 HIV/AIDS Related Orbitopathy |
|
|
323 | (9) |
|
15.2.1 HIV/AIDS Related Intraorbital Mucormycosis |
|
|
323 | (1) |
|
15.2.2 HIV/AIDS Related Intraorbital Lymphoma |
|
|
324 | (3) |
|
15.2.3 HIV/AIDS Related Fungal Suppurative Panophthalmitis |
|
|
327 | (3) |
|
15.2.4 HIV/AIDS Related Choroidal Tuberculosis |
|
|
330 | (2) |
|
15.3 HIV/AIDS Related Fundus Diseases |
|
|
332 | (23) |
|
15.3.1 HIV/AIDS Related Microangiopathy |
|
|
332 | (3) |
|
15.3.2 HIV/AIDS Related Cytomegalovirus Retinitis (CMVR) |
|
|
335 | (4) |
|
15.3.3 HIV/AIDS Related Varicella-Zoster Virus Retinitis |
|
|
339 | (4) |
|
15.3.4 HIV/AIDS Related Toxoplasma Retinitis with Accompanying Retinal Detachment |
|
|
343 | (1) |
|
15.3.5 HIV/AIDS Related Pneumocystis Carinii Retinitis |
|
|
344 | (2) |
|
15.3.6 HIV/AIDS Related Tuberculous Retinitis |
|
|
346 | (1) |
|
15.3.7 HIV/AIDS Related Cryptococcal Retinitis |
|
|
347 | (2) |
|
15.3.8 HIV/AIDS Related Optic Neuropathy |
|
|
349 | (1) |
|
15.3.9 HIV/AIDS Related Retinal Detachment |
|
|
350 | (1) |
|
15.3.10 HIV/AIDS Related Posterior Vitreous Detachment |
|
|
350 | (2) |
|
|
352 | (3) |
|
16 HIV/AIDS Related Neck Diseases |
|
|
355 | (22) |
|
16.1 An Overview of HIV/AIDS Related Neck Diseases |
|
|
355 | (1) |
|
16.2 HIV/AIDS Related Thyromegaly |
|
|
355 | (4) |
|
16.2.1 Pathogens and Pathogenesis |
|
|
355 | (2) |
|
16.2.2 Pathophysiological Basis |
|
|
357 | (1) |
|
16.2.3 Clinical Symptoms and Signs |
|
|
357 | (1) |
|
16.2.4 Examinations and Their Selection |
|
|
357 | (1) |
|
16.2.5 Imaging Demonstrations |
|
|
357 | (1) |
|
|
358 | (1) |
|
16.2.7 Criteria for the Diagnosis |
|
|
359 | (1) |
|
16.2.8 Differential Diagnosis |
|
|
359 | (1) |
|
16.3 HIV/AIDS Related Cervical Lymphoid Tuberculosis |
|
|
359 | (8) |
|
16.3.1 Pathogen and Pathogenesis |
|
|
359 | (1) |
|
16.3.2 Pathophysiological Basis |
|
|
360 | (1) |
|
16.3.3 Clinical Symptoms and Signs |
|
|
360 | (1) |
|
16.3.4 Examinations and Their Selection |
|
|
360 | (1) |
|
16.3.5 Imaging Demonstrations |
|
|
360 | (6) |
|
|
366 | (1) |
|
16.3.7 Criteria for the Diagnosis |
|
|
366 | (1) |
|
16.3.8 Differential Diagnosis |
|
|
366 | (1) |
|
16.4 HIV/AIDS Related Neoplasms |
|
|
367 | (4) |
|
16.4.1 Pathogen and Pathogenesis |
|
|
367 | (1) |
|
16.4.2 Clinical Symptoms and Signs |
|
|
367 | (1) |
|
16.4.3 Examinations and Their Selection |
|
|
367 | (1) |
|
16.4.4 Imaging Demonstrations |
|
|
368 | (3) |
|
16.4.5 Criteria for the Diagnosis |
|
|
371 | (1) |
|
16.4.6 Differential Diagnosis |
|
|
371 | (1) |
|
16.51 HIV/AIDS Related Paranasal Sinusitis |
|
|
371 | (6) |
|
16.5.1 Pathogen and Pathogenesis |
|
|
371 | (1) |
|
16.5.2 Pathophysiological Basis |
|
|
372 | (1) |
|
16.5.3 Clinical Symptoms and Signs |
|
|
372 | (1) |
|
16.5.4 Examinations and Their Selection |
|
|
372 | (1) |
|
16.5.5 Imaging Demonstrations |
|
|
373 | (2) |
|
16.5.6 Diagnostic Criteria |
|
|
375 | (1) |
|
16.5.7 Differential Diagnosis |
|
|
375 | (1) |
|
|
376 | (1) |
|
17 HIV/AIDS Related Respiratory Diseases |
|
|
377 | (160) |
|
17.1 General Overview of HIV/AIDS Related Respiratory Diseases |
|
|
377 | (6) |
|
17.1.1 AIDS Related Pulmonary Infections |
|
|
378 | (5) |
|
17.1.2 HIV/AIDS Related Pulmonary Tumors |
|
|
383 | (1) |
|
17.2 HIV/AIDS Related Pneumocystis Carnii Pneumonia (PCP) |
|
|
383 | (21) |
|
17.2.1 Pathogens and Pathogenesis |
|
|
384 | (1) |
|
17.2.2 Pathophysiological Basis |
|
|
384 | (1) |
|
17.2.3 Clinical Symptoms and Signs |
|
|
384 | (1) |
|
17.2.4 Examination Methods and Selections |
|
|
384 | (1) |
|
17.2.5 Imaging Demonstrations |
|
|
385 | (18) |
|
|
403 | (1) |
|
17.2.7 Differential Diagnosis |
|
|
403 | (1) |
|
|
404 | (1) |
|
17.3 HIV/AIDS Related Pulmonary Bacterial Infections |
|
|
404 | (54) |
|
17.3.1 HIV/AIDS Related Tuberculosis |
|
|
404 | (28) |
|
17.3.2 HIV/AIDS Related Pulmonary Nontuberculous Mycobacterial Infections |
|
|
432 | (2) |
|
17.3.3 HIV/AIDS Related Staphylococcus Aureus Pneumonia |
|
|
434 | (9) |
|
17.3.4 HIV/AIDS Related Rhodococcus Equi Pneumonia |
|
|
443 | (15) |
|
17.4 HIV/AIDS Related Pulmonary Fungal Infections |
|
|
458 | (41) |
|
17.4.1 HIV/AIDS Related Pulmonary Aspergillus Infection |
|
|
458 | (17) |
|
17.4.2 HIV/AIDS Related Pulmonary Cryptococcus Infection |
|
|
475 | (9) |
|
17.4.3 HIV/AIDS Related Pulmonary Candida Infection |
|
|
484 | (2) |
|
17.4.4 HIV/AIDS Related Penicillium Marneffei Infection |
|
|
486 | (12) |
|
17.4.5 HIV/AIDS Related Mucor Infection |
|
|
498 | (1) |
|
17.5 HIV/AIDS Related Pulmonary Virus Infection |
|
|
499 | (12) |
|
17.5.1 HIV/AIDS Related Cytomegalovirus Pneumonia |
|
|
499 | (5) |
|
17.5.2 HIV/AIDS Related Herpes Simplex Viral Pneumonia |
|
|
504 | (3) |
|
17.5.3 HIV/AIDS Related Lymphoid Interstitial Pneumonia |
|
|
507 | (4) |
|
17.6 HIV/AIDS Related Pulmonary Parasitic Diseases |
|
|
511 | (3) |
|
17.6.1 HIV/AIDS Related Pulmonary Toxoplasmosis |
|
|
511 | (3) |
|
17.6.2 HIV/AIDS Related Pulmonary Strongyloidiasis |
|
|
514 | (1) |
|
17.7 HIV/AIDS Related Pulmonary Neoplasms |
|
|
514 | (23) |
|
17.7.1 HIV/AIDS Related Lymphoma |
|
|
514 | (6) |
|
17.7.2 HIV/AIDS Related Kaposi's Sarcoma |
|
|
520 | (9) |
|
17.7.3 HIV/AIDS Related Lung Cancer |
|
|
529 | (4) |
|
|
533 | (4) |
|
18 HIV/AIDS Related Cardiac Diseases |
|
|
537 | (20) |
|
18.1 An Overview of HIV/AIDS Related Cardiac Diseases |
|
|
537 | (2) |
|
18.1.1 Pericardial Disease |
|
|
538 | (1) |
|
18.1.2 Pulmonary Hypertension |
|
|
538 | (1) |
|
|
538 | (1) |
|
18.1.4 Dilated Cardiomyopathy |
|
|
538 | (1) |
|
|
538 | (1) |
|
18.1.6 Valvular Heart Disease and Pulmonary Vascular Disease |
|
|
538 | (1) |
|
18.2 HIV/AIDS Related Pericarditis and Pericardial Effusion |
|
|
539 | (4) |
|
18.2.1 Pathogens and Pathogenesis |
|
|
539 | (1) |
|
18.2.2 Pathophysiological Basis |
|
|
539 | (1) |
|
18.2.3 Clinical Symptoms and Signs |
|
|
540 | (1) |
|
18.2.4 Examinations and Their Selection |
|
|
540 | (1) |
|
18.2.5 Imaging Demonstrations |
|
|
540 | (2) |
|
18.2.6 Criteria for the Diagnosis |
|
|
542 | (1) |
|
18.2.7 Differential Diagnosis |
|
|
542 | (1) |
|
18.3 HIV/AIDS Related Myocarditis and Cardiomyopathy |
|
|
543 | (6) |
|
18.3.1 HIV/AIDS Related Myocarditis |
|
|
543 | (3) |
|
18.3.2 HIV/AIDS Related Cardiomyopathy |
|
|
546 | (3) |
|
|
549 | (1) |
|
18.4 HIV/AIDS Related Endocardial Diseases |
|
|
549 | (2) |
|
18.5 HIV/AIDS Related Cardiac Tumors |
|
|
551 | (1) |
|
18.6 HIV/AIDS Related Vascular Diseases |
|
|
551 | (6) |
|
18.6.1 Venous Thrombosis and Pulmonary Embolism |
|
|
551 | (1) |
|
18.6.2 Pulmonary Hypertension |
|
|
552 | (1) |
|
|
553 | (3) |
|
|
556 | (1) |
|
19 HIV/AIDS Related Gastrointestinal Diseases |
|
|
557 | (62) |
|
19.1 An Overview of HIV/AIDS Related Gastrointestinal Diseases |
|
|
558 | (1) |
|
19.2 HIV/AIDS Related Viral Esophagitis |
|
|
559 | (3) |
|
19.2.1 HIV/AIDS Related CMV Esophagitis |
|
|
559 | (2) |
|
19.2.2 HIV/AIDS Related HSV Esophagitis |
|
|
561 | (1) |
|
19.2.3 HIV/AIDS Related Esophagitis |
|
|
562 | (1) |
|
19.3 HIV/AIDS Related Candida Esophagitis |
|
|
562 | (10) |
|
19.3.1 Pathogens and Pathogenesis |
|
|
562 | (1) |
|
19.3.2 Pathophysiological Basis |
|
|
562 | (1) |
|
19.3.3 Clinical Symptoms and Signs |
|
|
562 | (1) |
|
19.3.4 Examinations and Their Selection |
|
|
562 | (1) |
|
19.3.5 Imaging Demonstrations |
|
|
562 | (10) |
|
19.3.6 Criteria for the Diagnosis |
|
|
572 | (1) |
|
19.3.7 Differential Diagnosis |
|
|
572 | (1) |
|
19.4 HIV/AIDS Related Gastritis |
|
|
572 | (4) |
|
19.4.1 Pathogens and Pathogenesis |
|
|
572 | (1) |
|
19.4.2 Pathophysiological Basis |
|
|
572 | (1) |
|
19.4.3 Clinical Symptoms and Signs |
|
|
572 | (1) |
|
19.4.4 Examinations and Their Selection |
|
|
572 | (1) |
|
19.4.5 Imaging Demonstrations |
|
|
572 | (3) |
|
19.4.6 Criteria for the Diagnosis |
|
|
575 | (1) |
|
19.4.7 Differential Diagnosis |
|
|
576 | (1) |
|
19.5 HIV/AIDS Related Gastroduodenal Ulcer |
|
|
576 | (2) |
|
19.5.1 Pathogens and Pathogenesis |
|
|
576 | (1) |
|
19.5.2 Pathophysiological Basis |
|
|
576 | (1) |
|
19.5.3 Clinical Symptoms and Signs |
|
|
576 | (1) |
|
19.5.4 Examinations and Their Selection |
|
|
576 | (1) |
|
19.5.5 Imaging Demonstrations |
|
|
576 | (2) |
|
19.5.6 Criteria for the Diagnosis |
|
|
578 | (1) |
|
19.5.7 Differential Diagnosis |
|
|
578 | (1) |
|
19.6 HIV/AIDS Related Ileocecal Tuberculosis |
|
|
578 | (7) |
|
19.6.1 Pathogens and Pathogenesis |
|
|
578 | (1) |
|
19.6.2 Pathophysiological Basis |
|
|
579 | (1) |
|
19.6.3 Clinical Symptoms and Signs |
|
|
579 | (1) |
|
19.6.4 Examinations and Their Selection |
|
|
579 | (1) |
|
19.6.5 Imaging Demonstrations |
|
|
579 | (6) |
|
19.6.6 Criteria for the Diagnosis |
|
|
585 | (1) |
|
19.6.7 Differential Diagnosis |
|
|
585 | (1) |
|
19.7 HIV/AIDS Related Vesicorectal Fistula |
|
|
585 | (2) |
|
19.7.1 Pathogens and Pathogenesis |
|
|
585 | (1) |
|
19.7.2 Pathophysiological Basis |
|
|
585 | (1) |
|
19.7.3 Clinical Symptoms and Signs |
|
|
585 | (1) |
|
19.7.4 Examinations and Their Selection |
|
|
585 | (1) |
|
19.7.5 Imaging Demonstrations |
|
|
586 | (1) |
|
19.7.6 Criteria for the Diagnosis |
|
|
587 | (1) |
|
19.7.7 Differential Diagnosis |
|
|
587 | (1) |
|
19.8 HIV/AIDS Related Gastrointestinal Viral Infections |
|
|
587 | (3) |
|
19.8.1 HIV/AIDS Related Gastrointestinal Cytomegalovirus Infection |
|
|
587 | (1) |
|
19.8.2 HIV/AIDS Related Gastrointestinal Herpes Simplex Virus Infection |
|
|
588 | (1) |
|
19.8.3 HIV/AIDS Related Gastrointestinal Adenovirus Infection |
|
|
589 | (1) |
|
19.9 HIV/AIDS Related Gastrointestinal Bacterial Infections |
|
|
590 | (5) |
|
19.9.1 HIV/AIDS Related Gastrointestinal Mycobacterial Infection |
|
|
590 | (1) |
|
19.9.2 HIV/AIDS Related Gastrointestinal Salmonella Infection |
|
|
591 | (1) |
|
19.9.3 HIV/AIDS Related Gastrointestinal Shigella Infection |
|
|
592 | (1) |
|
19.9.4 HIV/AIDS Related Campylobacter Jejuni Infection |
|
|
593 | (1) |
|
19.9.5 HIV/AIDS Related Gastrointestinal Histoplasmosis |
|
|
593 | (2) |
|
19.10 HIV/AIDS Related Gastrointestinal Parasitosis |
|
|
595 | (6) |
|
19.10.1 HIV/AIDS Related Gastrointestinal Cryptosporidiosis |
|
|
595 | (1) |
|
19.10.2 HIV/AIDS Related Gastrointestinal Isosporiasis |
|
|
596 | (1) |
|
19.10.3 HIV/AIDS Related Gastrointestinal Entamoebiasis Histolytica |
|
|
597 | (1) |
|
19.10.4 HIV/AIDS Related Gastrointestinal Giardiasis |
|
|
598 | (1) |
|
19.10.5 HIV/AIDS Related Gastrointestinal Microsporidiosis |
|
|
599 | (1) |
|
19.10.6 HIV/AIDS Related Gastrointestinal Toxoplasmosis |
|
|
599 | (2) |
|
19.10.7 HIV/AIDS Related Strongyloidiasis |
|
|
601 | (1) |
|
19.11 HIV/AIDS Related Intestinal Tumors |
|
|
601 | (18) |
|
19.11.1 HIV/AIDS Related Intestinal Lymphoma |
|
|
601 | (6) |
|
19.11.2 HIV/AIDS Related Intestinal Kaposi's Sarcoma (KS) |
|
|
607 | (6) |
|
19.11.3 HIV/AIDS Related Other Gastrointestinal Tumors |
|
|
613 | (3) |
|
|
616 | (3) |
|
20 HIV/AIDS Related Hepatobiliary, Pancreatic and Splenic Diseases |
|
|
619 | (38) |
|
20.1 General Introduction to HIV/AIDS Related Hepatobiliary, Pancreatic and Splenic Diseases |
|
|
619 | (1) |
|
|
620 | (1) |
|
20.1.2 Gallbladder and Biliary Diseases |
|
|
620 | (1) |
|
|
620 | (1) |
|
20.1.4 Pancreatic Diseases |
|
|
620 | (1) |
|
20.2 HIV/AIDS Related Liver Tumor |
|
|
620 | (9) |
|
20.2.1 HIV/AIDS Related Lymphoma |
|
|
620 | (3) |
|
20.2.2 HIV/AIDS Related Kaposi Sarcoma (KS) |
|
|
623 | (3) |
|
20.2.3 HIV/AIDS Related Hepatic Hemangioma |
|
|
626 | (3) |
|
20.3 HIV/AIDS Related Viral Hepatitis |
|
|
629 | (5) |
|
20.3.1 HIV/AIDS Related Viral Hepatitis A |
|
|
630 | (1) |
|
20.3.2 HIV/AIDS Related Viral Hepatitis B |
|
|
630 | (1) |
|
20.3.3 HIV/AIDS Related Viral Hepatitis C |
|
|
631 | (1) |
|
20.3.4 HIV/AIDS Related Viral Hepatitis D |
|
|
632 | (1) |
|
20.3.5 HIV/AIDS Related Cirrhosis |
|
|
632 | (2) |
|
20.4 HIV/AIDS Related Hepatic Opportunistic Infections |
|
|
634 | (10) |
|
20.4.1 HIV/AIDS Related Hepatic CMV Infection |
|
|
634 | (1) |
|
20.4.2 HIV/AIDS Related Hepatic Tuberculosis |
|
|
635 | (5) |
|
20.4.3 HIV/AIDS Related Hepatic Non-tuberculosis Mycobacteria Infection |
|
|
640 | (2) |
|
20.4.4 HIV/AIDS Related Hepatic Parasitic Infection |
|
|
642 | (1) |
|
20.4.5 HIV/AIDS Related Hepatic Fungal Infection |
|
|
642 | (1) |
|
20.4.6 HIV/AIDS Related Hepatic Pneumocystis Carinii Infection |
|
|
643 | (1) |
|
20.4.7 HIV/AIDS Related Hepatic Bacterial Infection |
|
|
643 | (1) |
|
20.5 HIV/AIDS Related Biliary Inflammation |
|
|
644 | (4) |
|
20.5.1 Pathogens and Pathogenesis |
|
|
644 | (1) |
|
20.5.2 Pathophysiological Basis |
|
|
644 | (1) |
|
20.5.3 Clinical Symptoms and Signs |
|
|
644 | (1) |
|
20.5.4 Examinations and Their Selection |
|
|
645 | (1) |
|
20.5.5 Imaging Demonstrations |
|
|
645 | (3) |
|
|
648 | (1) |
|
20.5.7 Differential Diagnosis |
|
|
648 | (1) |
|
20.6 HIV/AIDS Related Splenic Diseases |
|
|
648 | (5) |
|
20.6.1 HIV/AIDS Caused Splenic Diseases |
|
|
648 | (1) |
|
20.6.2 HIV/AIDS Related Splenic Amyloid Diseases |
|
|
648 | (1) |
|
20.6.3 HIV/AIDS Related Splenic Malignancies |
|
|
649 | (2) |
|
20.6.4 HIV/AIDS Related Splenic Opportunistic Infections |
|
|
651 | (2) |
|
20.7 HIV/AIDS Related Pancreatic Diseases |
|
|
653 | (2) |
|
20.7.1 Pathogens and Pathogenesis |
|
|
653 | (1) |
|
20.7.2 Pathophysiological Basis |
|
|
653 | (1) |
|
20.7.3 Clinical Symptoms and Signs |
|
|
653 | (1) |
|
20.7.4 Examinations and Their Selection |
|
|
653 | (1) |
|
20.7.5 Imaging Demonstrations |
|
|
653 | (1) |
|
|
654 | (1) |
|
20.7.7 Differential Diagnosis |
|
|
654 | (1) |
|
20.8 HIV/AIDS Related Liver Cancer |
|
|
655 | (2) |
|
|
656 | (1) |
|
|
656 | (1) |
|
21 HIV/AIDS Related Peritoneal and Retroperitoneal Disease |
|
|
657 | (32) |
|
21.1 General Introduction to HIV/AIDS Related Peritoneal and Retroperitoneal Diseases |
|
|
657 | (1) |
|
21.2 HIV/AIDS Related Peritoneal and Retroperitoneal Lymphadenectasis |
|
|
658 | (18) |
|
21.2.1 HIV/AIDS Related Lymphadenectasis |
|
|
658 | (4) |
|
21.2.2 HIV/AIDS Related Mycobacterium Infectious Lymphadenectasis |
|
|
662 | (7) |
|
21.2.3 HIV/AIDS Related Penicillium Marneffei Infection |
|
|
669 | (7) |
|
21.3 HIV/AIDS Related Retroperitoneal Lymphoma |
|
|
676 | (7) |
|
21.3.1 Pathogens and Pathogenesis |
|
|
676 | (1) |
|
21.3.2 Pathophysiological Basis |
|
|
676 | (1) |
|
21.3.3 Clinical Symptoms and Signs |
|
|
676 | (1) |
|
21.3.4 Examinations and Their Selection |
|
|
677 | (1) |
|
21.3.5 Imaging Demonstrations |
|
|
677 | (5) |
|
|
682 | (1) |
|
21.3.7 Differential Diagnosis |
|
|
682 | (1) |
|
21.4 HIV/AIDS Related Primary Coelom Lymphoma |
|
|
683 | (6) |
|
21.4.1 Pathogens and Pathogenesis |
|
|
683 | (1) |
|
21.4.2 Pathophysiological Basis |
|
|
683 | (1) |
|
21.4.3 Clinical Symptom and Signs |
|
|
683 | (1) |
|
21.4.4 Examinations and Their Selection |
|
|
683 | (1) |
|
21.4.5 Imaging Demonstrations |
|
|
684 | (2) |
|
|
686 | (1) |
|
21.4.7 Differential Diagnosis |
|
|
686 | (1) |
|
|
686 | (1) |
|
|
687 | (2) |
|
22 HIV/AIDS Related Urogenital Disease |
|
|
689 | (20) |
|
22.1 An Overview of HIV/AIDS Related Urogenital Diseases |
|
|
689 | (1) |
|
22.2 HIV/AIDS Related Nephropathy |
|
|
690 | (1) |
|
22.2.1 Pathogen and Pathogenesis |
|
|
690 | (1) |
|
22.2.2 Pathophysiological Basis |
|
|
690 | (1) |
|
22.2.3 Clinical Symptoms and Signs |
|
|
690 | (1) |
|
22.2.4 Examinations and Their Selection |
|
|
690 | (1) |
|
22.2.5 Imaging Demonstrations |
|
|
690 | (1) |
|
|
690 | (1) |
|
22.2.7 Differential Diagnosis |
|
|
690 | (1) |
|
22.3 HIV/AIDS Related Urogenital Tuberculosis |
|
|
691 | (4) |
|
22.3.1 Pathogen and Pathogenesis |
|
|
691 | (1) |
|
22.3.2 Pathophysiological Basis |
|
|
691 | (1) |
|
22.3.3 Clinical Symptoms and Signs |
|
|
692 | (1) |
|
22.3.4 Examinations and Their Selection |
|
|
692 | (1) |
|
22.3.5 Imaging Demonstrations |
|
|
692 | (2) |
|
|
694 | (1) |
|
|
694 | (1) |
|
22.3.8 Differential Diagnosis |
|
|
694 | (1) |
|
22.4 HIV/AIDS Related Renal Failure |
|
|
695 | (2) |
|
22.4.1 Acute Renal Failure |
|
|
695 | (1) |
|
22.4.2 Chronic Renal Failure |
|
|
696 | (1) |
|
22.5 HIV/AIDS Related Cervical Carcinoma |
|
|
697 | (2) |
|
22.5.1 Pathogens and Pathogenesis |
|
|
697 | (1) |
|
22.5.2 Pathophysiological Basis |
|
|
697 | (1) |
|
22.5.3 Clinical Symptoms and Signs |
|
|
697 | (1) |
|
22.5.4 Examinations and Their Selection |
|
|
697 | (1) |
|
22.5.5 Imaging Demonstrations |
|
|
697 | (2) |
|
|
699 | (1) |
|
22.5.7 Differential Diagnosis |
|
|
699 | (1) |
|
22.6 HIV/AIDS Related Kidney Tumors |
|
|
699 | (4) |
|
22.6.1 HIV/AIDS Related Renal Carcinoma |
|
|
699 | (2) |
|
22.6.2 HIV/AIDS Related Renal Hodgkin's Lymphoma |
|
|
701 | (1) |
|
22.6.3 HIV/AIDS Related Kaposi's Sarcoma |
|
|
702 | (1) |
|
22.7 HIV/AIDS Related Urete and Bladder Diseases |
|
|
703 | (1) |
|
22.8 HIV/AIDS Related Other Renal Diseases |
|
|
703 | (6) |
|
22.8.1 HIV/AIDS Related Renal Calculus |
|
|
703 | (1) |
|
22.8.2 HIV/AIDS Related Renal Cyst |
|
|
704 | (2) |
|
22.8.3 HIV/AIDS Related Kidney Transplantation |
|
|
706 | (1) |
|
22.8.4 HIV/AIDS Related Renal Purulent Infection |
|
|
706 | (1) |
|
22.8.5 HIV/AIDS Related Renal Pneumocystis Carinii Infection |
|
|
707 | (1) |
|
22.8.6 HIV/AIDS Related Renal Candida Infection |
|
|
707 | (1) |
|
|
707 | (2) |
|
23 HIV/AIDS Related Musculoskeletal Diseases |
|
|
709 | (26) |
|
23.1 An Overview of HIV/AIDS Related Musculoskeletal Diseases |
|
|
709 | (1) |
|
23.1.1 Muscular and Soft Tissue Infections |
|
|
710 | (1) |
|
|
710 | (1) |
|
|
710 | (1) |
|
|
710 | (1) |
|
23.1.5 Rheumatic Diseases |
|
|
710 | (1) |
|
|
710 | (1) |
|
23.2 HIV/AIDS Related Osteomyelitis |
|
|
710 | (8) |
|
23.2.1 Pathogens and Pathogenesis |
|
|
710 | (1) |
|
23.2.2 Pathophysiological Basis |
|
|
711 | (1) |
|
23.2.3 Clinical Symptoms and Signs |
|
|
711 | (1) |
|
23.2.4 Examinations and Their Selection |
|
|
711 | (1) |
|
23.2.5 Imaging Demonstrations |
|
|
711 | (7) |
|
|
718 | (1) |
|
23.2.7 Differential Diagnosis |
|
|
718 | (1) |
|
23.3 HIV/AIDS Related Suppurative Myositis |
|
|
718 | (2) |
|
23.3.1 Pathogen and Pathogenesis |
|
|
718 | (1) |
|
23.3.2 Pathophysiological Basis |
|
|
718 | (1) |
|
23.3.3 Clinical Symptoms and Signs |
|
|
718 | (1) |
|
23.3.4 Examinations and Their Selection |
|
|
718 | (1) |
|
23.3.5 Imaging Demonstrations |
|
|
718 | (2) |
|
|
720 | (1) |
|
23.3.7 Differential Diagnosis |
|
|
720 | (1) |
|
23.4 HIV/AIDS Related Inflammatory Myopathy |
|
|
720 | (1) |
|
23.4.1 Pathogen and Pathogenesis |
|
|
720 | (1) |
|
23.4.2 Pathophysiological Basis |
|
|
720 | (1) |
|
23.4.3 Clinical Symptoms and Signs |
|
|
720 | (1) |
|
23.4.4 Examinations and Their Selection |
|
|
720 | (1) |
|
23.4.5 Imaging Demonstrations |
|
|
720 | (1) |
|
|
720 | (1) |
|
23.4.7 Differential Diagnosis |
|
|
721 | (1) |
|
23.5 HIV/AIDS Related Pine Moth Arthritis |
|
|
721 | (3) |
|
23.5.1 Pathogen and Pathogenesis |
|
|
721 | (1) |
|
23.5.2 Pathophysiological Basis |
|
|
721 | (1) |
|
23.5.3 Clinical Symptoms and Signs |
|
|
721 | (1) |
|
23.5.4 Imaging Demonstrations |
|
|
722 | (1) |
|
|
722 | (1) |
|
23.5.6 Differential Diagnosis |
|
|
722 | (2) |
|
23.6 HIV/AIDS Related Hemophilia |
|
|
724 | (1) |
|
23.7 HIV/AIDS Related Rheumatoid Diseases |
|
|
725 | (2) |
|
23.7.1 Pathogen and Pathogenesis |
|
|
725 | (1) |
|
23.7.2 Pathophysiological Basis |
|
|
725 | (1) |
|
23.7.3 Clinical Symptoms and Signs |
|
|
725 | (1) |
|
23.7.4 Examinations and Their Selection |
|
|
725 | (1) |
|
23.7.5 Imaging Demonstrations |
|
|
725 | (1) |
|
|
726 | (1) |
|
23.7.7 Differential Diagnosis |
|
|
726 | (1) |
|
23.8 HIV/AIDS Related Skeletal Syphilis |
|
|
727 | (2) |
|
23.8.1 Pathogen and Pathogenesis |
|
|
727 | (1) |
|
23.8.2 Pathophysiological Basis |
|
|
727 | (1) |
|
23.8.3 Clinical Symptoms and Signs |
|
|
727 | (1) |
|
23.8.4 Examinations and Their Selection |
|
|
727 | (1) |
|
23.8.5 Imaging Demonstrations |
|
|
727 | (2) |
|
|
729 | (1) |
|
23.8.7 Differential Diagnosis |
|
|
729 | (1) |
|
23.9 HIV/AIDS Related Vertebral Metastases |
|
|
729 | (6) |
|
23.9.1 Pathogen and Pathogenesis |
|
|
729 | (1) |
|
23.9.2 Pathophysiological Basis |
|
|
729 | (1) |
|
23.9.3 Clinical Symptoms and Signs |
|
|
729 | (1) |
|
23.9.4 Examinations and Their Selection |
|
|
729 | (1) |
|
23.9.5 Imaging Demonstrations |
|
|
730 | (3) |
|
|
733 | (1) |
|
23.9.7 Differential Diagnosis |
|
|
733 | (1) |
|
|
733 | (2) |
|
24 HIV/AIDS Related Pediatric Diseases |
|
|
735 | (34) |
|
24.1 An Overview of HIV/AIDS Related Pediatric Diseases |
|
|
736 | (1) |
|
24.2 HIV/AIDS Related Lymphoid Interstitial Pneumonia |
|
|
736 | (3) |
|
24.2.1 Pathogen and Pathogenesis |
|
|
736 | (1) |
|
24.2.2 Pathophysiological Basis |
|
|
736 | (1) |
|
24.2.3 Clinical Symptoms and Signs |
|
|
737 | (1) |
|
24.2.4 Examinations and Their Selection |
|
|
737 | (1) |
|
24.2.5 Imaging Demonstrations |
|
|
737 | (1) |
|
|
738 | (1) |
|
24.2.7 Differential Diagnosis |
|
|
738 | (1) |
|
24.3 HIV/AIDS Related Pulmonary Bacterial Infection |
|
|
739 | (8) |
|
24.3.1 Pathogen and Pathogenesis |
|
|
739 | (1) |
|
24.3.2 Pathophysiologic Basis |
|
|
739 | (1) |
|
24.3.3 Clinical Symptoms and Signs |
|
|
739 | (1) |
|
24.3.4 Examinations and Their Selection |
|
|
739 | (1) |
|
24.3.5 Imaging Demonstrations |
|
|
739 | (8) |
|
|
747 | (1) |
|
24.3.7 Differential Diagnosis |
|
|
747 | (1) |
|
24.4 HIV/AIDS Related Pneumocystis Carinii Pneumonia |
|
|
747 | (2) |
|
24.4.1 Pathogen and Pathogenesis |
|
|
747 | (1) |
|
24.4.2 Pathophysiologic Basis |
|
|
747 | (1) |
|
24.4.3 Clinical Symptoms and Signs |
|
|
747 | (1) |
|
24.4.4 Examinations and Their Selection |
|
|
747 | (1) |
|
24.4.5 Imaging Demonstrations |
|
|
748 | (1) |
|
|
749 | (1) |
|
24.4.7 Differential Diagnosis |
|
|
749 | (1) |
|
24.5 HIV/AIDS Related Miliary Tuberculosis |
|
|
749 | (2) |
|
24.5.1 Pathogen and Pathogenesis |
|
|
749 | (1) |
|
24.5.2 Pathophysiologic Basis |
|
|
749 | (1) |
|
24.5.3 Clinical Symptoms and Signs |
|
|
749 | (1) |
|
24.5.4 Examinations and Their Selection |
|
|
750 | (1) |
|
24.5.5 Imaging Demonstrations |
|
|
750 | (1) |
|
|
751 | (1) |
|
24.5.7 Differential Diagnosis |
|
|
751 | (1) |
|
24.6 HIV/AIDS Related Aspergillus Infection |
|
|
751 | (2) |
|
24.6.1 Pathogen and Pathogenesis |
|
|
751 | (1) |
|
24.6.2 Pathophysiological Basis |
|
|
751 | (1) |
|
24.6.3 Clinical Symptoms and Signs |
|
|
751 | (1) |
|
24.6.4 Examinations and Their Selections |
|
|
751 | (1) |
|
24.6.5 Imaging Demonstrations |
|
|
752 | (1) |
|
|
753 | (1) |
|
24.6.7 Differential Diagnosis |
|
|
753 | (1) |
|
24.7 HIV/AIDS Related Cerebral Atrophy and Infarction |
|
|
753 | (2) |
|
|
753 | (2) |
|
24.7.2 Cerebral Infarction |
|
|
755 | (1) |
|
24.8 HIV/AIDS Related Hepatic Lymphoma |
|
|
755 | (4) |
|
24.8.1 Pathogen and Pathogenesis |
|
|
755 | (1) |
|
24.8.2 Pathophysiologic Basis |
|
|
755 | (1) |
|
24.8.3 Clinical Symptoms and Signs |
|
|
756 | (1) |
|
24.8.4 Examinations and Their Selection |
|
|
756 | (1) |
|
24.8.5 Imaging Demonstrations |
|
|
756 | (3) |
|
|
759 | (1) |
|
24.8.7 Differential Diagnosis |
|
|
759 | (1) |
|
24.9 HIV/AIDS Related Hepatoblastoma |
|
|
759 | (3) |
|
24.9.1 Pathogen and Pathogenesis |
|
|
759 | (1) |
|
24.9.2 Pathophysiologic Basis |
|
|
759 | (1) |
|
24.9.3 Clinical Symptoms and Signs |
|
|
759 | (1) |
|
24.9.4 Examinations and Their Selection |
|
|
760 | (1) |
|
24.9.5 Imaging Demonstrations |
|
|
760 | (2) |
|
|
762 | (1) |
|
24.9.7 Differential Diagnosis |
|
|
762 | (1) |
|
24.10 HIV/AIDS Related Osteoporosis and Epiphyseal Sclerosis |
|
|
762 | (2) |
|
|
762 | (1) |
|
24.10.2 Epiphyseal Sclerosis |
|
|
763 | (1) |
|
24.11 HIV/AIDS Related Congenital Syphilis Infection |
|
|
764 | (5) |
|
24.11.1 Pathogen and Pathogenesis |
|
|
764 | (1) |
|
24.11.2 Pathophysiologic Basis |
|
|
764 | (1) |
|
24.11.3 Clinical Symptoms and Signs |
|
|
764 | (1) |
|
24.11.4 Examinations and Their Selection |
|
|
764 | (1) |
|
24.11.5 Imaging Demonstrations (X-ray) |
|
|
765 | (1) |
|
|
766 | (1) |
|
24.11.7 Differential Diagnosis |
|
|
766 | (1) |
|
|
767 | (2) |
|
25 HIV/AIDS Related Skin Diseases |
|
|
769 | (32) |
|
25.1 An Overview of HIV/AIDS Related Skin Diseases |
|
|
769 | (1) |
|
25.1.1 Bacillary Angioma or Bacillary Peliosis |
|
|
769 | (1) |
|
25.1.2 Herpes Simplex Virus Caused Primary or Recurrent Oral and Genital Diseases |
|
|
770 | (1) |
|
|
770 | (1) |
|
25.1.4 Molluscum Contagiosum |
|
|
770 | (1) |
|
|
770 | (1) |
|
25.1.6 Seborrheic Dermatitis |
|
|
770 | (1) |
|
25.1.7 Genital Candidiasis |
|
|
770 | (1) |
|
|
770 | (1) |
|
|
770 | (1) |
|
25.2 HIV/AIDS Related Fungal Infections |
|
|
770 | (7) |
|
25.2.1 HIV/AIDS Related Mucocutaneous Candidiasis |
|
|
770 | (2) |
|
25.2.2 HIV/AIDS Related Cryptococcal Infection |
|
|
772 | (2) |
|
25.2.3 HIV/AIDS Related Histoplasmosis Infection |
|
|
774 | (1) |
|
25.2.4 HIV/AIDS Related Superficial Fungal Infections |
|
|
775 | (2) |
|
25.3 HIV/AIDS Related Parasitic Infections |
|
|
777 | (1) |
|
25.3.1 HIV/AIDS Related Cutaneous Leishmaniasis |
|
|
777 | (1) |
|
25.3.2 HIV/AIDS Related Toxoplasma Infection of Skin |
|
|
777 | (1) |
|
25.4 HIV/AIDS Related Viral Infections |
|
|
777 | (6) |
|
25.4.1 HIV/AIDS Related Skin Herpes Simplex Virus Infection |
|
|
777 | (3) |
|
25.4.2 HIV/AIDS Related Skin Varicella-Zoster Virus Infection |
|
|
780 | (1) |
|
25.4.3 HIV/AIDS Related Skin Poxviridae Infection |
|
|
781 | (1) |
|
25.4.4 HIV/AIDS Related Skin Cytomegalovirus Infection |
|
|
781 | (1) |
|
25.4.5 HIV/AIDS Related Skin Human Papillomavirus Infection |
|
|
781 | (2) |
|
25.4.6 HIV/AIDS Related Skin Epstein-Barr (EB) Virus Infection |
|
|
783 | (1) |
|
25.5 HIV/AIDS Related Bacterial Infections |
|
|
783 | (3) |
|
25.5.1 Pathogen and Pathogenesis |
|
|
783 | (1) |
|
25.5.2 Pathophysiological Basis |
|
|
783 | (1) |
|
25.5.3 Clinical Symptoms and Signs |
|
|
784 | (1) |
|
25.5.4 Examinations and Their Selection |
|
|
784 | (2) |
|
25.6 HIV/AIDS Related Malignancies of Skin |
|
|
786 | (3) |
|
25.6.1 HIV/AIDS Related Skin Malignant Lymphoma |
|
|
786 | (1) |
|
25.6.2 HIV/AIDS Related Cutaneous Kaposi's Sarcoma |
|
|
786 | (3) |
|
25.7 HIV/AIDS Related Vascular Lesions of Skin |
|
|
789 | (1) |
|
25.7.1 HIV/AIDS Related Skin Bacillary Epithelioid Angiomatosis (BEA) |
|
|
789 | (1) |
|
25.8 HIV/AIDS Related Skin Dermatitis and Other Dermatologic Diseases |
|
|
790 | (11) |
|
25.8.1 HIV/AIDS Related Eosinophilic Folliculitis |
|
|
790 | (2) |
|
25.8.2 HIV/AIDS Related Acute Skin Rashes |
|
|
792 | (1) |
|
25.8.3 HIV/AIDS Related Skin Papular Prurigo |
|
|
792 | (1) |
|
25.8.4 HIV/AIDS Related Skin Seborrheic Dermatitis |
|
|
793 | (2) |
|
25.8.5 HIV/AIDS Related Skin Contact Dermatitis |
|
|
795 | (2) |
|
25.8.6 HIV/AIDS Related Medicament Tetter |
|
|
797 | (1) |
|
|
798 | (3) |
|
26 Functional Imaging of HIV/AIDS |
|
|
801 | (100) |
|
26.1 MR Functional Imaging in Neurological Diseases |
|
|
801 | (5) |
|
26.1.1 Diffusion Weighted Imaging (DWI) |
|
|
801 | (1) |
|
26.1.2 Diffusion Tensor Imaging (DTI) |
|
|
802 | (4) |
|
26.13 Perfusion Weighted Imaging (PWI) |
|
|
806 | (48) |
|
26.1.4 Blood Oxygenation Level Dependent fMR Imaging (fMRI-BOLD) |
|
|
807 | (1) |
|
26.1.5 Magnetic Resonance Spectroscopy (MRS) |
|
|
808 | (2) |
|
26.1.6 Clinical Application of Functional MR Imaging |
|
|
810 | (44) |
|
26.2 Functional Imaging of PET-CT for HIV/AIDS |
|
|
854 | (32) |
|
26.2.1 Brain PET-CT for HIV/AIDS |
|
|
854 | (15) |
|
26.2.2 Pulmonary PET-CT for HIV/AIDS |
|
|
869 | (17) |
|
26.3 Spectral CT Scanning for HIV/AIDS |
|
|
886 | (9) |
|
26.3.1 Pulmonary Spectral CT Scanning for HIV/AIDS |
|
|
886 | (4) |
|
26.3.2 Spectral CT Scanning for HIV/AIDS Related Lymphadenopathy |
|
|
890 | (3) |
|
26.3.3 Spectral CT Scanning for HIV/AIDS Related Neoplasms |
|
|
893 | (1) |
|
26.3.4 Spectral CT Scanning for Angiography of HIV/AIDS |
|
|
894 | (1) |
|
26.4 Clinic Application of Body Composition Assessment Methods in HIV/AIDS |
|
|
895 | (6) |
|
26.4.1 Skinfold Thickness Measurement |
|
|
895 | (1) |
|
26.4.2 Sonographic Assessment |
|
|
895 | (1) |
|
26.4.3 Bioelectrical Impedance Analysis |
|
|
896 | (1) |
|
|
896 | (1) |
|
|
896 | (2) |
|
|
898 | (3) |
Index |
|
901 | |